Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 May;14(5):476-477.
doi: 10.1038/cmi.2016.27. Epub 2016 Jun 6.

Exosomes: multitask cargo carriers modulating innate immunity to viruses

Affiliations
Comment

Exosomes: multitask cargo carriers modulating innate immunity to viruses

Mario U Mondelli. Cell Mol Immunol. 2017 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Proposed mechanisms of exosome-mediated propagation of HBV infection and modulation of NK-cell responses. HBV-infected hepatocytes release fully competent virions that can be recognized by HBV receptor such as the NTCP and transmit the infection to neighboring hepatocytes. Infection can also be conveyed by viral nucleic acid-loaded exosomes originated by HBV-infected hepatocytes in a receptor-independent manner. Exosomes regulate NK-cell responses by dampening intracellular innate sensing by RIG-I, which results in down-modulation of the NKp44 activating receptor and up-regulation of the NKG2A inhibitory receptor. NK-cell phenotypic changes are accompanied by reduced IFN-γ production and impaired cytolytic activity. Which of the many components of the exosome cargo is responsible for impaired innate immune responses is still unknown. HBV, hepatitis B virus; IFN-γ, interferon-γ NK, natural killer; NTCP, sodium-taurocholate co-transporting polypeptide; RIG-I, retinoic acid-inducible gene 1.

Comment on

Similar articles

References

    1. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 2004; 350: 1118–1129. - PubMed
    1. Maini MK, Gehring AJ. The role of innate immunity in the immunopathology and treatment of HBV infection. J Hepatol 2016; 64: S60–S70. - PubMed
    1. Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol 2016; 64: S71–S83. - PubMed
    1. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44–49. - PMC - PubMed
    1. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9: 495–502. - PMC - PubMed

LinkOut - more resources